MicroRNA-421 is a new potential diagnosis biomarker with higher sensitivity and specificity than carcinoembryonic antigen and cancer antigen 125 in gastric cancer

Biomarkers

Volumn 20, Issue 1, 2015, Pages 58-63

  Wu, Jianhong ^a   Li, Guangxin ^b   Yao, Yongliang ^a   Wang, Zeyou ^c   Sun, Wangwei ^a   Wang, Jianjun ^a  

^a JIANGSU UNIVERSITY   (China)

^b Chongqing General Hospital   (China)

^c CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Cancer antigen 125; Carcinoembryonic antigen; Gastric cancer; MicroRNA 421; Tumor marker

Indexed keywords

CA 125 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; MICRORNA; MICRORNA 421; UNCLASSIFIED DRUG; MIRN421 MICRORNA, HUMAN;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CANCER DIAGNOSIS; CANCER PATIENT; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATIONAL STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PREDICTION; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; STOMACH CANCER; BLOOD; CASE CONTROL STUDY; RECEIVER OPERATING CHARACTERISTIC; STOMACH NEOPLASMS;

CA-125 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; MICRORNAS; ROC CURVE; STOMACH NEOPLASMS;

EID: 84921822593     PISSN: 1354750X     EISSN: 13665804     Source Type: Journal    
DOI: 10.3109/1354750X.2014.992812     Document Type: Article

References (31)

1. Ahmed FE. (2007). Role of miRNA in carcinogenesis and biomarker selection: a methodological view. Expert Rev Mol Diagn 7:569-603.
2. Association WM. (2000). Declaration of Helsinki, ethical principles for medical research involving human subjects. 52nd WMA General Assembly, Edinburgh, Scotland.
3. Bast Jr RC, Klug TL, St John E, et al. (1983). A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer. N Engl J Med 309:883-7.
4. Calin GA, Sevignani C, Dumitru CD, et al. (2004). Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci USA 101:2999-3004.
5. Cui L, Zhang X, Ye G, et al. (2013). Gastric juice MicroRNAs as potential biomarkers for the screening of gastric cancer. Cancer 119:1618-26.
6. Danaei G, Vander Hoorn S, Lopez AD, et al. (2005). Causes of cancer in the world: comparative risk assessment of nine behavioural and environmental risk factors. Lancet 366:1784-93.
7. Dunnwald LK, Rossing MA, Li CI. (2007). Hormone receptor status, tumor characteristics, and prognosis: a prospective cohort of breast cancer patients. Breast Cancer Res 9:R6.
8. Ebert MP, Rocken C. (2006). Molecular screening of gastric cancer by proteome analysis. Eur J Gastroenterol Hepatol 18:847-53.
9. Ferlay J, Shin HR, Bray F, et al. (2010). Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127:2893-917.
10. Filipowicz W, Bhattacharyya SN, Sonenberg N. (2008). Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet 9:102-14
11. Guo J, Miao Y, Xiao B, et al. (2009). Differential expression of microRNA species in human gastric cancer versus non-tumorous tissues. J Gastroenterol Hepatol 24:652-7.
12. Hiyoshi Y, Kamohara H, Karashima R, et al. (2009). MicroRNA-21 regulates the proliferation and invasion in esophageal squamous cell carcinoma. Clin Cancer Res 15:1915-22.
13. Hobert O. (2008). Gene regulation by transcription factors and microRNAs. Science 319:1785-6.
14. Holmström MB, Johansson M, Bergh A, et al. (2009). Prostate specific antigen for early detection of prostate cancer: longitudinal study. BMJ 339:b3537. doi: 10.1136/bmj.b3537.
15. Iorio MV, Croce CM. (2012). MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review. EMBO Mol Med 4:143-59.
16. Ishiguro H, Kimura M, Takeyama H. (2014). Role of microRNAs in gastric cancer. World J Gastroenterol 20:5694-9.
17. Jemal A, Bray F, Center MM, et al. (2011). Global cancer statistics. CA Cancer J Clin 61:69-90.
18. Jiang Z, Guo J, Xiao B, et al. (2010). Increased expression of miR-421 in human gastric carcinoma and its clinical association. J Gastroenterol 45:17-23.
19. Johnson PJ, Leung N, Cheng P, et al. (1997). 'Hepatoma-specific'alphafetoprotein may permit preclinical diagnosis of malignant change in patients with chronic liver disease. Br J Cancer 75:236-40.
20. Konishi H, Ichikawa D, Komatsu S, et al. (2012). Detection of gastric cancer-associated microRNAs on microRNA microarray comparing pre- and post-operative plasma. Br J Cancer 106:740-7.
21. Li PF, Chen SC, Xia T, et al. (2014). Non-coding RNAs and gastric cancer. World J Gastroenterol 20:5411-19.
22. Liu H, Zhu L, Liu B, et al. (2012). Genome-wide microRNA profiles identify miR-378 as a serum biomarker for early detection of gastric cancer. Cancer Lett 316:196-203.
23. Lu J, Getz G, Miska EA, et al. (2005). MicroRNA expression profiles classify human cancers. Nature 435:834-8.
24. Meng F, Henson R, Wehbe-Janek H, et al. (2007). MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 133:647-58.
25. Moriyama T, Ohuchida K, Mizumoto K, et al. (2009). MicroRNA-21 modulates biological functions of pancreatic cancer cells including their proliferation, invasion, and chemoresistance. Mol Cancer Ther 8:1067-74.
26. Pineles BL, Romero R, Montenegro D, et al. (2007). Distinct subsets of microRNAs are expressed differentially in the human placentas of patients with preeclampsia. Am J Obstet Gynecol 196:261.e1-6.
27. Valencia-Sanchez MA, Liu J, Hannon GJ, Parker R. (2006). Control of translation and mRNA degradation by miRNAs and siRNAs. Genes Dev 20:515-24.
28. Yanagawa T, Hayashi Y, Nishida T, et al. (1986). Immunohistochemical demonstration of carcinoembryonic antigen (CEA) on tissue sections from squamous cell head and neck cancer and plasma CEA levels of the patients. Int J Oral Maxillofac Surg 15:296-306.
29. Zhang X, Cui L, Ye G, et al. (2012). Gastric juice microRNA-421 is a new biomarker for screening gastric cancer. Tumour Biol 33:2349-55.
30. Zhou H, Guo JM, Lou YR, et al. (2010). Detection of circulating tumor cells in peripheral blood from patients with gastric cancer using microRNA as a marker. J Mol Med (Berl) 88:709-17.
31. Zhou H, Xiao B, Zhou F, et al. (2012). MiR-421 is a functional marker of circulating tumor cells in gastric cancer patients. Biomarkers 17:104-10.